Net benefit of statins for primary prevention of cardiovascular disease in people 75 years or older: a benefit-harm balance modeling study
Background: We determined the risk thresholds above which statin use would be more likely to provide a net benefit for people over the age of 75 years without history of cardiovascular disease (CVD). Methods: An exponential model was used to estimate the differences in expected benefit and harms in...
Saved in:
Main Authors: | Henock G. Yebyo (Author), Hélène E. Aschmann (Author), Dominik Menges (Author), Cynthia M. Boyd (Author), Milo A. Puhan (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2019-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Older adult preferences regarding benefits and harms of statin and aspirin therapy for cardiovascular primary prevention
by: Frances M. Wang, et al.
Published: (2023) -
Statin Therapy and Cognitive Impairment: Benefit or Harm?
by: O. D. Ostroumova, et al.
Published: (2018) -
Physical Activity in Polluted Air-Net Benefit or Harm to Cardiovascular Health? A Comprehensive Review
by: Omar Hahad, et al.
Published: (2021) -
Sun Exposure in Children: Balancing the Benefits and Harms
by: Ankur K Jindal, et al.
Published: (2020) -
SARS-CoV-2 Quarantine Mandated by Contact Tracing: Burden and Infection Rate Among Close Contacts in Zurich, Switzerland, 2020-2021
by: Hélène Eloise Aschmann, et al.
Published: (2024)